Pamela L. Kunz
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Oncology
Key Documents
Contact Information
-
Clinical Offices
Medical Oncology 875 Blake Wilbur Dr MC 5826 Stanford, CA 94305 Tel Work (650) 725-8738 Fax (650) 498-4696
- Academic Offices
Alternate Contact Rochelle Wallach Administrative Associate Email Tel Work 650-725-8738Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer
- Cancer> GI Oncology
- Esophageal Cancer
- Gastrointestinal Cancers
- Neuroendocrine
- Oncology (Cancer)
Professional Education
| Fellowship: | Stanford Hospital and Clinics CA (2007) |
| Residency: | Stanford University School of Medicine CA (2004) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2010) |
| Board Certification: | Oncology, ABIM (2010) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2004) |
| Medical Education: | Dartmouth Medical School NH (2001) |
Scientific Focus
Current Research Interests
I specialize in the treatment of gastrointestinal malignancies. My research involves clinical trials and epidemiologic studies, primarily in neuroendocrine and gastroesophageal cancers.
Clinical Trials
- Not Recruiting Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
- Not Recruiting A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
- Not Recruiting Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
- Not Recruiting Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
- Recruiting A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Publications
- Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors. Pancreas. 2013; (4): 557-577
- Everolimus causing severe hypertriglyceridemia and acute pancreatitis. J Natl Compr Canc Netw. 2013; (1): 5-9
- Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement? Ann Surg Oncol. 2013; (5): 1631-8
- Capecitabine-induced chest pain relieved by diltiazem. Am J Cardiol. 2012; (11): 1623-6
- HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment. Appl Immunohistochem Mol Morphol. 2012; (1): 13-24
- Long-term survivors of gastric cancer: a California population-based study. J Clin Oncol. 2012; (28): 3507-15
Help
Trial Administration